Supplementary Data from Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP Inhibitors

2026 Open access

Read full text
Authors: Zheng-Cheng Yu, Tianhe Li, Ellen Tully, Peng Huang, Chih‐Ning Chen, Philipp Oberdoerffer, Stephanie L. Gaillard, Ie‐Ming Shih, Tian‐Li Wang
DOI: 10.1158/0008-5472.31084541
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Chromatin Remodeling and Cancer Glioma Diagnosis and Treatment

Publication details

Publication date
19 January 2026